CHEK1 and Miyoshi myopathy: Here we report that Chk1/MEK1/2 inhibition induces pronounced apoptosis in bortezomib-resistant MM cells exhibiting Mcl-1 up-regulation, and overcomes drug resistance stemmed from IL-6, IGF-1, or stromal cells.